Automated Microscopy Compared for Routine Malaria Diagnosis
By LabMedica International staff writers Posted on 10 Oct 2018 |

Image: The Autoscope uses deep-learning software to quantify the malaria parasites in a sample (Photo courtesy of Intellectual Ventures).
Microscopic examination of Giemsa-stained blood films remains a major form of diagnosis in malaria case management. However, as with other visualization-based diagnoses, accuracy depends on individual technician performance, making standardization difficult and reliability poor.
Automated image recognition based on machine-learning, utilizing convolutional neural networks, offers potential to overcome these drawbacks. The application of digital image recognition to malaria microscopy, using artificial intelligence algorithms to replace or supplement the human factor in blood film interpretation, have been attempted, usually on thin films.
A team of scientists collaborating with Intellectual Ventures (Bellevue, WA, USA) conducted a cross-sectional, observational trial was conducted at two peripheral primary health facilities in Peru. They enrolled 700 participants whose age was between 5 and 75 years, and had a history of fever in the last three days or elevated temperature on admission. A finger prick blood sample was taken to create blood films for microscopy diagnosis, and additional drops of blood were spotted onto filter paper for subsequent quantitative polymerase chain reaction (qPCR) analysis. A prototype digital microscope device employing an algorithm based on machine-learning, the Autoscope, was assessed for its potential in malaria microscopy.
The investigators reported that at one clinic, sensitivity of Autoscope for diagnosing malaria was 72% and specificity was 85%. Microscopy performance was similar to Autoscope, with sensitivity 68% and specificity 100%. At one clinic, 85% of prepared slides had a minimum of 600 white blood cells (WBCs) imaged, thus meeting Autoscope’s design assumptions. At the second clinic, the sensitivity of Autoscope was 52% and specificity was 70%. Microscopy performance at this second clinic was 42% and specificity was 97%. Only 39% of slides from this clinic met Autoscope’s design assumptions regarding WBCs imaged.
The authors concluded that Autoscope’s diagnostic performance was on par with routine microscopy when slides had adequate blood volume to meet its design assumptions, as represented by results from one clinic. Autoscope’s diagnostic performance was poorer than routine microscopy on slides from the other clinic, which generated slides with lower blood volumes. The study was published on September 25, 2018, in the Malaria Journal.
Related Links:
Intellectual Ventures
Automated image recognition based on machine-learning, utilizing convolutional neural networks, offers potential to overcome these drawbacks. The application of digital image recognition to malaria microscopy, using artificial intelligence algorithms to replace or supplement the human factor in blood film interpretation, have been attempted, usually on thin films.
A team of scientists collaborating with Intellectual Ventures (Bellevue, WA, USA) conducted a cross-sectional, observational trial was conducted at two peripheral primary health facilities in Peru. They enrolled 700 participants whose age was between 5 and 75 years, and had a history of fever in the last three days or elevated temperature on admission. A finger prick blood sample was taken to create blood films for microscopy diagnosis, and additional drops of blood were spotted onto filter paper for subsequent quantitative polymerase chain reaction (qPCR) analysis. A prototype digital microscope device employing an algorithm based on machine-learning, the Autoscope, was assessed for its potential in malaria microscopy.
The investigators reported that at one clinic, sensitivity of Autoscope for diagnosing malaria was 72% and specificity was 85%. Microscopy performance was similar to Autoscope, with sensitivity 68% and specificity 100%. At one clinic, 85% of prepared slides had a minimum of 600 white blood cells (WBCs) imaged, thus meeting Autoscope’s design assumptions. At the second clinic, the sensitivity of Autoscope was 52% and specificity was 70%. Microscopy performance at this second clinic was 42% and specificity was 97%. Only 39% of slides from this clinic met Autoscope’s design assumptions regarding WBCs imaged.
The authors concluded that Autoscope’s diagnostic performance was on par with routine microscopy when slides had adequate blood volume to meet its design assumptions, as represented by results from one clinic. Autoscope’s diagnostic performance was poorer than routine microscopy on slides from the other clinic, which generated slides with lower blood volumes. The study was published on September 25, 2018, in the Malaria Journal.
Related Links:
Intellectual Ventures
Latest Hematology News
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
Troponin is a protein found in heart muscle cells that is released into the bloodstream when the heart is damaged. High-sensitivity troponin blood tests are commonly used in hospitals to diagnose heart... Read more
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more